Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Isoniazid | Research

Effect of mobile-phone messaging on patient and health-worker knowledge and adherence to the isoniazid preventive therapy guideline in HIV clinics in Southeast, Nigeria

Authors: Ifeyinwa Chizoba Akamike, Ijeoma Nkem Okedo-Alex, Chihurumnanya Alo, Adaoha Pearl Agu, Chigozie Jesse Uneke, Lawrence Ulu Ogbonnaya

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

HIV-infected persons are at increased risk of developing tuberculosis and Isoniazid preventive therapy has been shown to reduce the occurrence of tuberculosis among this group of persons. M-health technology has been reported to increase both knowledge and implementation of various health services including Isoniazid preventive therapy implementation. This study aimed to determine the effect of m-health on health worker knowledge and adherence to isoniazid preventive therapy (IPT) guidelines and on patient knowledge and adherence to isoniazid treatment.

Methods

This was a quasi-experimental study that was carried out in six health facilities in Ebonyi State, southeast Nigeria. Three health facilities were assigned to each arm (intervention and control arms) and all eligible health workers (total population of 45 and 41 in intervention and control arms respectively) were recruited. Data were also collected from 200 patients (100 per arm). The intervention consisted of mobile phone messages and reminders for health workers on the IPT guideline. Chi-square test was carried out at p < 0.05 and 95% confidence interval.

Results

At baseline, 54.5% and 63.4% of health workers in intervention and control arms respectively had good knowledge which improved significantly to 90.2% in the intervention arm after the intervention (χ2 = 14.22, p < 0.0001). At baseline, 61.4% and 90.2% of health workers had good adherence to the guideline in intervention and control arms respectively which also improved in the intervention arm by 28.8% after intervention although not significant(χ2 = 0.37, p = 0.54). More than 50% of the patients in both study arms had poor knowledge, with the intervention arm having a significantly higher proportion of respondents (68.0%) with poor knowledge at baseline (χ2 = 4.71, p = 0.03). The proportion of patients with good knowledge however increased significantly (88.8%) in the intervention arm after intervention (χ2 = 25.65, p < 0.001). Patients had good adherence to IPT in intervention and control arms before (100% and 84.2% respectively) and after (96.6% and 100% respectively) the study. There was no significant difference in adherence among patients in both arms.

Conclusions

Health worker knowledge and practice of guidelines as well as patient knowledge improved in the intervention arm in this study. These findings suggest the consideration for the inclusion of mobile phone reminders in the guideline for tuberculosis prevention among HIV patients.
Literature
1.
go back to reference Alarcon E, Bissell K, Boillot F, Caminero JA, Chiang C, Clevenbergh P, et al. Isoniazid preventive therapy for people living with HIV : public health challenges and implementation issues. Int J Tuberc Lung Dis. 2015;13(8):927–35. Alarcon E, Bissell K, Boillot F, Caminero JA, Chiang C, Clevenbergh P, et al. Isoniazid preventive therapy for people living with HIV : public health challenges and implementation issues. Int J Tuberc Lung Dis. 2015;13(8):927–35.
2.
go back to reference Makanjuola T, Taddese HB, Booth A. Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data. PLoS ONE. 2014;9(2):e87166.CrossRef Makanjuola T, Taddese HB, Booth A. Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data. PLoS ONE. 2014;9(2):e87166.CrossRef
3.
go back to reference Getachew Y, Mekonnen W. Correlates of adherence and utilization of Isoniazid preventive therapy in HIV patients. J Microbiol Infect Dis. 2015;5:45–50.CrossRef Getachew Y, Mekonnen W. Correlates of adherence and utilization of Isoniazid preventive therapy in HIV patients. J Microbiol Infect Dis. 2015;5:45–50.CrossRef
5.
go back to reference Hiransuthikul N, Hiransuthikul P, Nelson KE, Jirawisit M, Paewplot R, Kasak S, et al. Physician adherence to isoniazid preventive therapy guidelines for HIV infected patients in Thailand. Southeast Asian J Trop Med Public Heal. 2005;36(5):1208–15. Hiransuthikul N, Hiransuthikul P, Nelson KE, Jirawisit M, Paewplot R, Kasak S, et al. Physician adherence to isoniazid preventive therapy guidelines for HIV infected patients in Thailand. Southeast Asian J Trop Med Public Heal. 2005;36(5):1208–15.
8.
go back to reference Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain MLM, et al. Predictors of latent tuberculosis treatment initiation and completion at a U. S. public health clinic : a prospective cohort study. BMC Public Health. 2012;12:468.CrossRef Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain MLM, et al. Predictors of latent tuberculosis treatment initiation and completion at a U. S. public health clinic : a prospective cohort study. BMC Public Health. 2012;12:468.CrossRef
9.
go back to reference Adams LV, Talbot EA, Odato K, Blunt H, Steingart KR. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis. 2014;14(1):281.CrossRef Adams LV, Talbot EA, Odato K, Blunt H, Steingart KR. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis. 2014;14(1):281.CrossRef
10.
go back to reference De ADS, Paula A. Factors associated with treatment for latent tuberculosis in persons living with HIV / AIDS Fatores associados ao tratamento da tuberculose latente em pessoas vivendo com HIV/AIDS Factores asociados al tratamiento de la tuberculosis latente en personas. Cad saúde pública. 2015;31(12):2505–13.CrossRef De ADS, Paula A. Factors associated with treatment for latent tuberculosis in persons living with HIV / AIDS Fatores associados ao tratamento da tuberculose latente em pessoas vivendo com HIV/AIDS Factores asociados al tratamiento de la tuberculosis latente en personas. Cad saúde pública. 2015;31(12):2505–13.CrossRef
11.
go back to reference Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS. 1996;11(1):107–12.CrossRef Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS. 1996;11(1):107–12.CrossRef
12.
go back to reference Yamin A, Bornstein E, Hensel R, Mohamed O, Kempker RR. Predictors of latent tuberculosis infection treatment after introduction of a new regimen : a retrospective cohort study at an inner city clinic. Open Forum Infect Dis. 2016;(Cdc):1–6. Yamin A, Bornstein E, Hensel R, Mohamed O, Kempker RR. Predictors of latent tuberculosis infection treatment after introduction of a new regimen : a retrospective cohort study at an inner city clinic. Open Forum Infect Dis. 2016;(Cdc):1–6.
13.
go back to reference Shayo GA, Moshiro C, Aboud S, Bakari M, Mugusi FM. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania. BMC Infect Dis. 2015;15:368.CrossRef Shayo GA, Moshiro C, Aboud S, Bakari M, Mugusi FM. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania. BMC Infect Dis. 2015;15:368.CrossRef
14.
go back to reference Schneider MP, Krummenacher I, Figueiredo H, Marquis J, Bugnon O. Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract (Granada). 2009;7(2):63–73.CrossRef Schneider MP, Krummenacher I, Figueiredo H, Marquis J, Bugnon O. Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract (Granada). 2009;7(2):63–73.CrossRef
15.
go back to reference Berhe M, Demissie M, Tesfaye G. Isoniazid preventive therapy adherence and associated factors among HIV positive patients in Addis Ababa, Ethiopia. Adv Epiemiol. 2014;2014:1.CrossRef Berhe M, Demissie M, Tesfaye G. Isoniazid preventive therapy adherence and associated factors among HIV positive patients in Addis Ababa, Ethiopia. Adv Epiemiol. 2014;2014:1.CrossRef
16.
go back to reference Mindachew M, Deribew A, Tessema F, Biadgilign S, Smoll M, Shafer F, et al. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. BMC Public Health. 2011;11(1):916.CrossRef Mindachew M, Deribew A, Tessema F, Biadgilign S, Smoll M, Shafer F, et al. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. BMC Public Health. 2011;11(1):916.CrossRef
17.
go back to reference Federal Ministry of Health Department of public health. Guideline for isoniazid preventive therapy. 2014. Federal Ministry of Health Department of public health. Guideline for isoniazid preventive therapy. 2014.
18.
go back to reference World Health Organisation. mHealth: new horizons for health through mobile technologies. Glob Obs eHealth Ser. 2011;3:5–6. World Health Organisation. mHealth: new horizons for health through mobile technologies. Glob Obs eHealth Ser. 2011;3:5–6.
20.
go back to reference Lau YK, Cassidy T, Hacking D, Brittain K, Haricharan HJ, Heap M. Antenatal health promotion via short message service at a Midwife Obstetrics Unit in South Africa: a mixed methods study. BMC Pregnancy Childbirth. 2014;14(1):284.CrossRef Lau YK, Cassidy T, Hacking D, Brittain K, Haricharan HJ, Heap M. Antenatal health promotion via short message service at a Midwife Obstetrics Unit in South Africa: a mixed methods study. BMC Pregnancy Childbirth. 2014;14(1):284.CrossRef
21.
go back to reference Richman AR, Maddy L, Torres E, Goldberg EJ. A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students. J Am Coll Heal. 2016;64(4):269–78.CrossRef Richman AR, Maddy L, Torres E, Goldberg EJ. A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students. J Am Coll Heal. 2016;64(4):269–78.CrossRef
22.
go back to reference Lee HY, Koopmeiners JS, McHugh J, Raveis VH, Ahluwalia JS. mhealth pilot study: text messaging intervention to promote HPV vaccination. Am J Health Behav. 2016;40(1):67–76.CrossRef Lee HY, Koopmeiners JS, McHugh J, Raveis VH, Ahluwalia JS. mhealth pilot study: text messaging intervention to promote HPV vaccination. Am J Health Behav. 2016;40(1):67–76.CrossRef
24.
go back to reference Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. 2013;16(3):302–8.CrossRef Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. 2013;16(3):302–8.CrossRef
25.
go back to reference Heather C-L, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56–69.CrossRef Heather C-L, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56–69.CrossRef
26.
go back to reference Nglazi MD, Bekker L, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment : a systematic review. BMC Infect Dis. 2013;13:566.CrossRef Nglazi MD, Bekker L, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment : a systematic review. BMC Infect Dis. 2013;13:566.CrossRef
27.
go back to reference Kitahata MM, Tegger MK, Wagner EH, Holmes KK. Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002;325:954–7.CrossRef Kitahata MM, Tegger MK, Wagner EH, Holmes KK. Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002;325:954–7.CrossRef
28.
go back to reference Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, et al. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396–401.CrossRef Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, et al. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396–401.CrossRef
30.
go back to reference Tikuye AM, Tikuye AM. Knowledge, attitudes and practices of health care providers towards isoniazide preventive therapy (IPT) provision in Addis Ababa, Ethiopia; 2013. Tikuye AM, Tikuye AM. Knowledge, attitudes and practices of health care providers towards isoniazide preventive therapy (IPT) provision in Addis Ababa, Ethiopia; 2013.
31.
go back to reference Lawan BM, Agu KA. Assessment of short term Isoniazid Preventive Therapy ( IPT ) in people living with HIV/AIDS. West Afr J Pharm. 2018;29(1):46–58. Lawan BM, Agu KA. Assessment of short term Isoniazid Preventive Therapy ( IPT ) in people living with HIV/AIDS. West Afr J Pharm. 2018;29(1):46–58.
32.
go back to reference Manissero D, Marieke J, Langendam M, Huitric E. Knowledge of tuberculosis-treatment prescription of health workers: a systematic review. Eur Respir J. 2012;39(5):1248–55.CrossRef Manissero D, Marieke J, Langendam M, Huitric E. Knowledge of tuberculosis-treatment prescription of health workers: a systematic review. Eur Respir J. 2012;39(5):1248–55.CrossRef
33.
go back to reference Akamike IC, Okedo-alex IN, Uneke CJ, Uro-chukwu C, Chukwu OE, Ugwu NI, et al. Evaluation of the effect of an educational intervention on knowledge and adherence to HIV guidelines among frontline health workers in Alex-Ekwueme Federal University Teaching Hospital Abakaliki, Nigeria. Afr Health Sci. 2020;20(3):1080–9.CrossRef Akamike IC, Okedo-alex IN, Uneke CJ, Uro-chukwu C, Chukwu OE, Ugwu NI, et al. Evaluation of the effect of an educational intervention on knowledge and adherence to HIV guidelines among frontline health workers in Alex-Ekwueme Federal University Teaching Hospital Abakaliki, Nigeria. Afr Health Sci. 2020;20(3):1080–9.CrossRef
34.
go back to reference Abdulrazaak AT, Govender I, Nzaumvila D, Group F. Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy in HIV/AIDS patients at Odi District Hospital, Gauteng province, South Africa Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy i. South African J Infect Dis. 2018;0053. Abdulrazaak AT, Govender I, Nzaumvila D, Group F. Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy in HIV/AIDS patients at Odi District Hospital, Gauteng province, South Africa Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy i. South African J Infect Dis. 2018;0053.
35.
go back to reference Denegetu AW, Dolamo BL. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia : a cross-sectional facility based study. BMC Public Health. 2014;14:52.CrossRef Denegetu AW, Dolamo BL. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia : a cross-sectional facility based study. BMC Public Health. 2014;14:52.CrossRef
36.
go back to reference Ngombo AM. Factors affecting implementation of isoniazid preventive therapy in HIV/AIDS clinics in Dar es Salaam Region, Tanzania. 2013; Ngombo AM. Factors affecting implementation of isoniazid preventive therapy in HIV/AIDS clinics in Dar es Salaam Region, Tanzania. 2013;
37.
go back to reference Saraceni V, Antonio G, Jonathan G, Victoria V, Bonnie K, Solange C, et al. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Brazilian J Infect Dis. 2011;15(3):249–52. Saraceni V, Antonio G, Jonathan G, Victoria V, Bonnie K, Solange C, et al. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Brazilian J Infect Dis. 2011;15(3):249–52.
38.
go back to reference Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised. PLoS Med. 2015;12(9):1–18.CrossRef Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised. PLoS Med. 2015;12(9):1–18.CrossRef
40.
go back to reference World Health Organization. Global diffusion of eHealth, Making universal health coverage achievable: report on the Third Global Survey on eHealth Geneva. 2016. World Health Organization. Global diffusion of eHealth, Making universal health coverage achievable: report on the Third Global Survey on eHealth Geneva. 2016.
41.
go back to reference Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients’ knowledge on adherence to their chronic medications: a cross-sectional study in Jordan. Int J Clin Pharm. 2015;37:504.CrossRef Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients’ knowledge on adherence to their chronic medications: a cross-sectional study in Jordan. Int J Clin Pharm. 2015;37:504.CrossRef
Metadata
Title
Effect of mobile-phone messaging on patient and health-worker knowledge and adherence to the isoniazid preventive therapy guideline in HIV clinics in Southeast, Nigeria
Authors
Ifeyinwa Chizoba Akamike
Ijeoma Nkem Okedo-Alex
Chihurumnanya Alo
Adaoha Pearl Agu
Chigozie Jesse Uneke
Lawrence Ulu Ogbonnaya
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06759-4

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.